Prohibit certain provisions in insurance policies and health plans relating to clinician-administered drugs and change provisions relating to pharmacy benefit managers

Nebraska's LB 109 prohibits health insurers and pharmacy benefit managers (PBMs) from imposing restrictions that limit patient access to clinician-administered drugs - such as those given in a doctor's office or clinic rather than a pharmacy. It bans insurers from charging extra fees, requiring specific pharmacy use, or denying coverage when drugs are administered by healthcare providers. The bill also requires PBMs to allow pharmacists to discuss treatment options, costs, and alternatives with patients and prohibits penalizing pharmacies for sharing information about their practices. These changes directly affect insurers, health plans, and PBMs in how they handle drug coverage and patient communications.